• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Arcutis Biotherapeutics, Inc. - Common stock (NQ:ARQT)

    30.20 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Jan 5, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 30.20
    Bid (Size) 30.05 (500)
    Ask (Size) 31.00 (1,000)
    Prev. Close 30.20
    Today's Range 30.20 - 30.20
    52wk Range 11.13 - 31.77
    Shares Outstanding 50,241,789
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Arcutis Biotherapeutics (NASDAQ:ARQT) Combines High-Growth Momentum with Bullish Technical Setup ↗
    Arcutis Biotherapeutics (ARQT) combines strong revenue growth & earnings momentum with a bullish technical chart setup, signaling a potential breakout opportunity. 
    Via Chartmill
    News headline image
    Arcutis Stock Is Up 100% in a Year but Here’s Why One Fund Still Sold 1 Million Shares ↗
    Even after cutting back, this remains the fund’s largest bet and the timing lines up with a pivotal stretch for Arcutis’ pipeline. 
    Via The Motley Fool

    Performance

    YTD
    +4.1%
    +4.1%
    1 Month
    -2.7%
    -2.7%
    3 Month
    +52.8%
    +52.8%
    6 Month
    +125.5%
    +125.5%
    1 Year
    +105.3%
    +105.3%

    More News

    Read More
    News headline image
    Fund Discloses Increased Mineralys Bet Amid 200% Stock Run as New Drug Application Nears ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    The Biotech Renaissance: Innovation and M&A Frenzy Spark a Historic Year-End Rally
    Via MarketMinute
    Topics ETFs Economy Intellectual Property
    News headline image
    This Biotech Stock Could Cure Your Portfolio's Pain ↗
    Via The Motley Fool
    News headline image
    ARCUTIS BIOTHERAPEUTICS INC (NASDAQ:ARQT) Shows Strong Technical and Fundamental Momentum ↗
    Via Chartmill
    News headline image
    Arcutis Strengthens Board of Directors with New Appointment of Amit Munshi and Honors Retirement of Bhaskar Chaudhuri
    From Arcutis Biotherapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Why Shares in Arcutis Biotherapeutics Surged Again This Week ↗
    Via The Motley Fool
    News headline image
    10 Health Care Stocks With Whale Alerts In Today's Session ↗
    Via Benzinga
    News headline image
    FDA Accepts Supplemental New Drug Application for Arcutis’ ZORYVE® (roflumilast) Cream 0.3% for the Treatment of Plaque Psoriasis in Children Ages 2 to 5
    From Arcutis Biotherapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Peering Into Arcutis Biotherapeutics Inc's Recent Short Interest ↗
    Via Benzinga
    News headline image
    Arcutis Completes Enrollment in INTEGUMENT-INFANT Phase 2 Study Evaluating ZORYVE® (roflumilast) Cream 0.05% in Infants with Atopic Dermatitis
    From Arcutis Biotherapeutics, Inc.
    Via GlobeNewswire
    News headline image
    ARCUTIS BIOTHERAPEUTICS INC (NASDAQ:ARQT) Combines Strong Trend with High-Growth Momentum ↗
    Via Chartmill
    News headline image
    Arcutis Announces Publication of Positive Long-Term Safety and Efficacy Data of ZORYVE® (roflumilast) Foam 0.3% in Individuals with Seborrheic Dermatitis in American Journal of Clinical Dermatology
    From Arcutis Biotherapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Mother-Daughter Duo, Tori Spelling and Stella McDermott, Partner With Arcutis Biotherapeutics in the Free to Be Me Campaign, Urging People With Inflammatory Skin Conditions to Speak With Their Healthcare Provider About Long-Term Treatments
    From Arcutis Biotherapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Arcutis Launches ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Mild to Moderate Atopic Dermatitis in Children Ages 2 to 5
    From Arcutis Biotherapeutics, Inc.
    Via GlobeNewswire
    News headline image
    These stocks are moving in today's session ↗
    Via Chartmill
    News headline image
    Arcutis Q3 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Top stock movements in today's session. ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
    Via Benzinga
    News headline image
    Crude Oil Falls Over 2%; PayPal Shares Spike Higher ↗
    Via Benzinga
    News headline image
    Here's Why This Biotherapeutics Company's Stock Surged Higher by 30% Today ↗
    Via The Motley Fool
    News headline image
    Arcutis Tops A Profit-Taking Zone After Smashing Forecasts. But There Was Another Surprise. ↗
    Via Investor's Business Daily
    News headline image
    Traders are paying attention to the gapping stocks in Tuesday's session. ↗
    Via Chartmill
    News headline image
    Wayfair, Qorvo, Celestica, United Parcel Service, Regeneron Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday ↗
    Via Benzinga

    Frequently Asked Questions

    Is Arcutis Biotherapeutics, Inc. - Common stock publicly traded?
    Yes, Arcutis Biotherapeutics, Inc. - Common stock is publicly traded.
    What exchange does Arcutis Biotherapeutics, Inc. - Common stock trade on?
    Arcutis Biotherapeutics, Inc. - Common stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Arcutis Biotherapeutics, Inc. - Common stock?
    The ticker symbol for Arcutis Biotherapeutics, Inc. - Common stock is ARQT on the Nasdaq Stock Market
    What is the current price of Arcutis Biotherapeutics, Inc. - Common stock?
    The current price of Arcutis Biotherapeutics, Inc. - Common stock is 30.20
    When was Arcutis Biotherapeutics, Inc. - Common stock last traded?
    The last trade of Arcutis Biotherapeutics, Inc. - Common stock was at 01/05/26 04:00 PM ET
    What is the market capitalization of Arcutis Biotherapeutics, Inc. - Common stock?
    The market capitalization of Arcutis Biotherapeutics, Inc. - Common stock is 1.52B
    How many shares of Arcutis Biotherapeutics, Inc. - Common stock are outstanding?
    Arcutis Biotherapeutics, Inc. - Common stock has 2B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.